See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Prime Day
Amazon
James Gunn
Artificial Intelligence
Social Media
Natural Disasters
Donald Trump
Novak Djokovic
Floods
Democratic Party
Crime
Education
Published • loading... • Updated

New Alzheimer’s drug disappoints in trials

Summary by Ground News
Gantenerumab is part of a class of injected drugs designed to remove sticky protein pieces called beta amyloid from the brain. A buildup of those pieces is a hallmark of Alzheimer's. Roche, the company behind the drug, said it appeared to remove less of the protein pieces than expected.

8 Articles

All
Left
Center
7
Right
nbc29.comnbc29.com
Center

New Alzheimer’s drug disappoints in trials

An experimental treatment for Alzheimer’s disease has shown disappointing results in clinical trials, according to new information from the makers of the drug.

Read Full Article
Hawaii News NowHawaii News Now
Center

New Alzheimer’s drug disappoints in trials

An experimental treatment for Alzheimer’s disease has shown disappointing results in clinical trials, according to new information from the makers of the drug.

·Honolulu, United States
Read Full Article
KPLC NewsKPLC News
Center

New Alzheimer’s drug disappoints in trials

An experimental treatment for Alzheimer’s disease has shown disappointing results in clinical trials, according to new information from the makers of the drug.

·Lake Charles, United States
Read Full Article
Live5NewsLive5News
Center

New Alzheimer’s drug disappoints in trials

An experimental treatment for Alzheimer’s disease has shown disappointing results in clinical trials, according to new information from the makers of the drug.

Read Full Article
FOX CarolinaFOX Carolina
Center

New Alzheimer’s drug disappoints in trials

An experimental treatment for Alzheimer’s disease has shown disappointing results in clinical trials, according to new information from the makers of the drug.

·South Carolina, United States
Read Full Article
WPTAWPTA
Center

New Alzheimer’s drug disappoints in trials

An experimental treatment for Alzheimer’s disease has shown disappointing results in clinical trials, according to new information from the makers of the drug.

·Fort Wayne, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

KCRG broke the news in Cedar Rapids, United States on Wednesday, November 16, 2022.
Sources are mostly out of (0)

Similar News Topics

Alzheimer's Disease icon

Alzheimer's Disease

Alzheimer's Disease icon

Alzheimer's Disease

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal